企業プロフィール
Arcus Biosciences 株価・ニュース・カタリスト
- ティッカー:
- RCUS
- 取引所:
- NYSE
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
29.56 USD (+0.27%)
終値
最終更新: 2026年8月17日
3.08B USD
時価総額
株価変動の要因
As of Aug 17, 2026, RCUS closed up 0.27% at $29.56. No new same-company headline was identified in the current news window.
企業概要
事業概要
Arcus Biosciences is an oncology company focused on immuno-oncology combinations and targeted cancer therapies. Its platform is built to create differentiated regimens in solid tumors.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Arcus sits in clinical-stage oncology biotechnology.
ビジネスモデルの特徴
The company depends on clinical data, partnership economics, and the ability to translate combination science into durable cancer programs.
バイオ業界での位置付け
Arcus is a catalyst-sensitive oncology name whose stock moves on readouts, combination strategy, and partner progress.
今後のカタリスト
- Arcus's catalysts are domvanalimab/zimberelimab combinations and casdatifan in oncology, where the next readouts determine whether the platform can keep its premium. The company remains a key immuno-oncology and HIF-2α story.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。